Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00209950
Status:
COMPLETED
Last Update Posted:
2007-03-30
First Post:
2005-09-13
Brief Title:
A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia
Sponsor:
H Lundbeck AS
Organization:
H Lundbeck AS
Study Overview
Official Title:
A Prospective Open-Label Extension Study to Study 99784 of Gaboxadol in Primary Insomnia
Status:
COMPLETED
Status Verified Date:
2007-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the safety and tolerability of gaboxadol in primary insomnia
Detailed Description:
To evaluate long-term safety of gaboxadol in healthy adults
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None